248 related articles for article (PubMed ID: 25049204)
1. Hepatocyte growth factor-like protein is a positive regulator of early mammary gland ductal morphogenesis.
Gurusamy D; Ruiz-Torres SJ; Johnson AL; Smith DA; Waltz SE
Mech Dev; 2014 Aug; 133():11-22. PubMed ID: 25049204
[TBL] [Abstract][Full Text] [Related]
2. HGFL supports mammary tumorigenesis by enhancing tumor cell intrinsic survival and influencing macrophage and T-cell responses.
Benight NM; Wagh PK; Zinser GM; Peace BE; Stuart WD; Vasiliauskas J; Pathrose P; Starnes SL; Waltz SE
Oncotarget; 2015 Jul; 6(19):17445-61. PubMed ID: 25938541
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte growth factor-like protein is required for prostate tumor growth in the TRAMP mouse model.
Vasiliauskas J; Nashu MA; Pathrose P; Starnes SL; Waltz SE
Oncotarget; 2014 Jul; 5(14):5547-58. PubMed ID: 24980820
[TBL] [Abstract][Full Text] [Related]
4. Gas6 is dispensable for pubertal mammary gland development.
Mills KL; Gomes AM; Standlee CR; Rojo MD; Carmeliet P; Lin Z; Machado HL
PLoS One; 2018; 13(12):e0208550. PubMed ID: 30533018
[TBL] [Abstract][Full Text] [Related]
5. The Ron receptor tyrosine kinase negatively regulates mammary gland branching morphogenesis.
Meyer SE; Zinser GM; Stuart WD; Pathrose P; Waltz SE
Dev Biol; 2009 Sep; 333(1):173-85. PubMed ID: 19576199
[TBL] [Abstract][Full Text] [Related]
6. CD151 represses mammary gland development by maintaining the niches of progenitor cells.
Yin Y; Deng X; Liu Z; Baldwin LA; Lefringhouse J; Zhang J; Hoff JT; Erfani SF; Rucker EB; O'Connor K; Liu C; Wu Y; Zhou BP; Yang XH
Cell Cycle; 2014; 13(17):2707-22. PubMed ID: 25486358
[TBL] [Abstract][Full Text] [Related]
7. β-Catenin is required for Ron receptor-induced mammary tumorigenesis.
Wagh PK; Gray JK; Zinser GM; Vasiliauskas J; James L; Monga SP; Waltz SE
Oncogene; 2011 Aug; 30(34):3694-704. PubMed ID: 21423209
[TBL] [Abstract][Full Text] [Related]
8. Constitutive overexpression of Id-1 in mammary glands of transgenic mice results in precocious and increased formation of terminal end buds, enhanced alveologenesis, delayed involution.
Shin DH; Jang SH; Kang BC; Kim HJ; Oh SH; Kong G
J Cell Physiol; 2011 May; 226(5):1340-52. PubMed ID: 20945346
[TBL] [Abstract][Full Text] [Related]
9. Conditional deletion of Stat3 in mammary epithelium impairs the acute phase response and modulates immune cell numbers during post-lactational regression.
Hughes K; Wickenden JA; Allen JE; Watson CJ
J Pathol; 2012 May; 227(1):106-17. PubMed ID: 22081431
[TBL] [Abstract][Full Text] [Related]
10. Terminal end bud maintenance in mammary gland is dependent upon FGFR2b signaling.
Parsa S; Ramasamy SK; De Langhe S; Gupte VV; Haigh JJ; Medina D; Bellusci S
Dev Biol; 2008 May; 317(1):121-31. PubMed ID: 18381212
[TBL] [Abstract][Full Text] [Related]
11. Single cell transcriptome atlas of mouse mammary epithelial cells across development.
Pal B; Chen Y; Milevskiy MJG; Vaillant F; Prokopuk L; Dawson CA; Capaldo BD; Song X; Jackling F; Timpson P; Lindeman GJ; Smyth GK; Visvader JE
Breast Cancer Res; 2021 Jun; 23(1):69. PubMed ID: 34187545
[TBL] [Abstract][Full Text] [Related]
12. Met-related receptor tyrosine kinase Ron in tumor growth and metastasis.
Wagh PK; Peace BE; Waltz SE
Adv Cancer Res; 2008; 100():1-33. PubMed ID: 18620091
[TBL] [Abstract][Full Text] [Related]
13. Mammary gland specific expression of Brk/PTK6 promotes delayed involution and tumor formation associated with activation of p38 MAPK.
Lofgren KA; Ostrander JH; Housa D; Hubbard GK; Locatelli A; Bliss RL; Schwertfeger KL; Lange CA
Breast Cancer Res; 2011 Sep; 13(5):R89. PubMed ID: 21923922
[TBL] [Abstract][Full Text] [Related]
14. Loss of Alx4, a stromally-restricted homeodomain protein, impairs mammary epithelial morphogenesis.
Joshi PA; Chang H; Hamel PA
Dev Biol; 2006 Sep; 297(1):284-94. PubMed ID: 16916507
[TBL] [Abstract][Full Text] [Related]
15. Postnatal mammary gland development requires macrophages and eosinophils.
Gouon-Evans V; Rothenberg ME; Pollard JW
Development; 2000 Jun; 127(11):2269-82. PubMed ID: 10804170
[TBL] [Abstract][Full Text] [Related]
16. Regulation of epithelial cell turnover and macrophage phenotype by epithelial cell-derived transforming growth factor beta1 in the mammary gland.
Sun X; Robertson SA; Ingman WV
Cytokine; 2013 Feb; 61(2):377-88. PubMed ID: 23290315
[TBL] [Abstract][Full Text] [Related]
17. The mouse mammary gland requires the actin-binding protein gelsolin for proper ductal morphogenesis.
Crowley MR; Head KL; Kwiatkowski DJ; Asch HL; Asch BB
Dev Biol; 2000 Sep; 225(2):407-23. PubMed ID: 10985859
[TBL] [Abstract][Full Text] [Related]
18. Transforming growth factor-beta signaling-deficient fibroblasts enhance hepatocyte growth factor signaling in mammary carcinoma cells to promote scattering and invasion.
Cheng N; Chytil A; Shyr Y; Joly A; Moses HL
Mol Cancer Res; 2008 Oct; 6(10):1521-33. PubMed ID: 18922968
[TBL] [Abstract][Full Text] [Related]
19. Ron receptor-dependent gene regulation of Kupffer cells during endotoxemia.
Kulkarni RM; Stuart WD; Waltz SE
Hepatobiliary Pancreat Dis Int; 2014 Jun; 13(3):281-92. PubMed ID: 24919612
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of TLR4-induced IκB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein.
Ray M; Yu S; Sharda DR; Wilson CB; Liu Q; Kaushal N; Prabhu KS; Hankey PA
J Immunol; 2010 Dec; 185(12):7309-16. PubMed ID: 21078906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]